Screener
Eton Pharmaceuticals, Inc. ETON Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed August 13, 2026.
- Filed
- Aug 13, 2026, 4:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-027684
| Line item | For the three months ended / June 30, 2026 | For the three months ended / June 30, 2025 | For the six months ended / June 30, 2026 | For the six months ended / June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Product sales, net | $37,589 | $18,928 | $61,855 | $32,924 |
| Licensing revenue | — | — | — | 3,286 |
| Total net revenues | 37,589 | 18,928 | 61,855 | 36,210 |
| Cost of sales: | ||||
| Product sales and royalties, net | 12,176 | 7,004 | 21,707 | 13,600 |
| Licensing revenue | — | — | — | 825 |
| Total cost of sales | 12,176 | 7,004 | 21,707 | 14,425 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s total revenue?
- Eton Pharmaceuticals, Inc. (ETON) reported total revenue of $37.59M in Q2 2026.
- How has Eton Pharmaceuticals, Inc.'s total revenue changed year-over-year?
- Eton Pharmaceuticals, Inc.'s total revenue increased by 98.6% year-over-year, from $18.93M to $37.59M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s total revenue has grown at a 38.3% compound annual growth rate (CAGR), from $21.83M to $79.95M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Eton Pharmaceuticals, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude